Journal Guide

Endocrine Connections publishes original quality research in all areas of endocrinology, with a focus on papers that have relevance to its related and intersecting disciplines and the wider biomedical community. The journal considers basic, translational and clinical studies.

• Signaling mechanisms - endocrine disruption by chemicals that mimic/antagonize all classes of hormones: reproductive and metabolic hormones, morphogens, detoxification systems, vitamins, and orphans--via all hormone binding proteins and metabolic pathways.
• Endocrine disruption-based disease - e.g. reproductive, developmental, immunologic, metabolic, behavioral, oncologic-including both preclinical and epidemiologic studies.
• High throughput, structure-based, and modeling methodologies - in silico compound docking, medium?high throughput screening methods, structure-activity studies, and database approaches. The study of mixtures, low-doses, non-monotonic dose behavior, and their environmental relevancy.
• Experimental models - the suitability of cell and animal models for assessing endocrine disruptor activities.
• Perinatal origins of adult disease - the fetal, postnatal and multigenerational basis of adult disease, and emerging examples of epigenetic control and endocrine disruptor-mediated imprinting of changes in gene expression.
• Natural endocrine disruptors - e.g. phyto-hormones, phyco-hormones- and their disease, drug interaction, or therapeutic targets.
• Cross-training for chemists and biologists- facilitating the interface of green chemistry design/remediation with endocrinology, aimed at eliminating future endocrine-disrupting chemicals from consumer products.
• Public policy - the crafting of public policy to prevent and remediate endocrine disruption.
• Education and Outreach - community outreach, public education, translation to stake-holders, and web sites devoted to exposing or solving the endocrine disruption problem.

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.

This journal publishes original articles relating to endocrinology in the broadest context. Subjects of interest include: receptors and mechanism of action of hormones, methodological advances in the detection and measurement of hormones; structure and chemical properties of hormones. Invitations to submit Brief Reviews are issued to specific authors by the Editors.

Endocrine Reviews publishes bimonthly comprehensive, authoritative, and timely review articles balancing both experimental and clinical endocrinology themes and crystallizing the most significant clinical experience and current research in endocrinology and related areas such as cell biology, immunology, pharmacology, genetics, molecular biology, neuroscience, reproductive medicine, and pediatric endocrinology. In the 2009 Journal Citation Report, Endocrine Reviews has the highest Impact Factor ranking of the 105 journals in the category of Endocrinology and Metabolism: 19.761.

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders. Original articles related to Immune Disorders and Drug Targeting are also considered for publication.

Endocrine-Related Cancer is the established global journal for basic, translational and clinical research on hormones and cancer. Endocrine-related cancers typically include cancers of the breast, prostate, pituitary, testes, ovary and neuroendocrine system as well as hormone-dependent cancers elsewhere.

Endocrinology, the Society's oldest journal, has defined the science of endocrinology for most of the twentieth century. One of the most authoritative biomedical research journals in the world, it publishes 6,000 pages annually of the highest quality original work ranging from subcellular mechanisms to whole animal physiology. Topics include bone and mineral; growth factors; reproductive/steroids; neuroendocrinology/signal transduction; thyroid; and physiology. The low manuscript acceptance rate of 30% reflects the degree to which it is committed to the highest scientific standard. In the 2009 Thomson Reuters Journal Citation Report, Endocrinology received a 5-Year Impact Factor of 5.103. Published monthly.

Endocrinology Insights is an open-access, peer-reviewed journal with a dedicated focus on advancing the understanding of endocrinology, diabetes, and metabolism. It is the official journal of the Portuguese Society of Endocrinology, Diabetes and Metabolism (SPEDM). Tailored for Endocrinology professionals engaged in clinical practice or research, the journal publishes high-quality original basic, translational, and clinical research, reviews, meta-analyses, case reports presenting a novel insight, and commentaries. The journal particularly welcomes guidelines, consensus and position statements that impact clinical practice.

Endocrinology and Metabolism Clinics of North America updates you on the latest trends in patient management, keeps you abreast of the newest advances, and provides a sound basis for choosing treatment options. Published quarterly—in March, June, September, and December—each issue features expert, state-of-the-art reviews on a single topic, including obesity, diabetes, thyroid disease, bone disorders, reproduction, hypertension, and much more.